Effects of a topical enamel matrix derivative on skin wound healing

Wound Repair and Regeneration

Volumn 12, Issue 1, 2004, Pages 100-108

  Mirastschijski, Ursula ^a   Konrad, Daniel ^b   Lundberg, Eva ^c   Lyngstadaas, Staale Petter ^c,d   Jorgensen, Lars N ^e   Ågren, Magnus S ^e,f  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RCC Ltd   (Switzerland)

^c BIORA AB   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

^e BISPEBJERG HOSPITAL   (Denmark)

^f Aagren Dermaconsulting ApS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID PROPYLENE GLYCOL ESTER; AMELOGENIN; EMDOGAIN; GELATINASE A; GROWTH FACTOR; PROTEINASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DOSE RESPONSE; ENAMEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EPITHELIZATION; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; GRANULATION TISSUE; MALE; MICROVASCULATURE; NONHUMAN; PERIODONTICS; PERIODONTITIS; PRIORITY JOURNAL; RABBIT; SKIN INJURY; TISSUE REGENERATION; WOUND CLOSURE; WOUND HEALING;

EID: 1342281770     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-475x.2004.tb00001.x     Document Type: Article

References (45)

1. Gestrelius S, Andersson C, Johansson AC, Persson E, Brodin A, Rydhag L, Hammarström L. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 1997;24:678-84.
2. Fincham AG, Moradian-Oldak J, Diekwisch TG, Lyaruu DM, Wright JT, Bringas P Jr, Slavkin HC. Evidence for amelogenin 'nanospheres' as functional components of secretory-stage enamel matrix. J Struct Biol 1995;115:50-9.
3. Lyngstadaas SP, Risnes S, Nordbo H, Flones AG. Amelogenin gene similarity in vertebrates: DNA sequences encoding amelogenin seem to be conserved during evolution. J Comp Physiol [B] 1990;160:469-72.
4. Paine ML, Lei YP, Dickerson K, Snead ML. Altered amelogenin self-assembly based on mutations observed in human X-linked amelogenesis imperfecta (AIH1). J Biol Chem 2002;277:17112-6.
5. Zeichner-David M. Is there more to enamel matrix proteins than biomineralization? Matrix Biol 2001;20:307-16.
6. Heijl L, Heden G, Svärdström G, Östgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-14.
7. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-9.
8. Esposito M, Coulthard P, Worthington HV. Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects. (Cochrane Review) In: The Cochrane Library, Issue 2, 2003 Oxford: Update Software.
9. Wennström JL, Lindhe J. Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 2002;29:9-14.
10. Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Invest 2002;6:183-7.
11. Hoang AM, Klebe RJ, Steffensen B, Ryu OH, Simmer JP, Cochran DL. Amelogenin is a cell adhesion protein. J Dent Res 2002;81:497-500.
12. Hoang AM, Oates TW, Cochran DL. In vitro wound healing responses to enamel matrix derivative. J Periodontol 2000;71:1270-7.
13. Van der Pauw MT, Van den Bos T, Everts V, Beertsen W. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor betal release of periodontal ligament and gingival fibroblasts. J Periodontol 2000;71:31-43.
14. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28:181-8.
15. Okubo K, Kobayashi M, Takiguchi T, Takada T, Ohazama A, Okamatsu Y, Hasegawa K. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. J Periodontal Res 2003;38:1-9.
16. Gestrelius S, Andemson C, Lidström D, Hammarström L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24:685-92.
17. Haase HR, Bartold PM. Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. J Periodontol 2001;72:341-8.
18. Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, Daniels J, Khaw PT, Thomas DW. Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol 2001;144:229-37.
19. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol 2000;115:225-33.
20. Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana Pollock JS, Brock TL, McNeil PL. Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 2001;96:173-82.
21. Maycock J, Wood SR, Brookes SJ, Shore RC, Robinson C, Kirkham J. Characterization of a porcine amelogenin preparation, Emdogain, a biological treatment for periodontal disease. Connect Tissue Res 2002;43:472-6.
22. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-77.
23. Brett PM, Parkar M, Olsen I, Tonetti M. Expression profiling of periodontal ligament cells stimulated with enamel matrix proteins in vitro: a model for tissue regeneration. J Dent Res 2002;81:776-83.
24. Van der Pauw MT, Everts V, Beertsen W. Expression of integrins by human periodontal ligament and gingival fibroblasts and their involvement in fibroblast adhesion to enamel matrix-derived proteins. J Periodontal Res 2002;37:317-23.
25. Ruangpanit N, Chan D, Holmbeck K, Birkedal-Hansen H, Polarek J, Yang C, Bateman JF, Thompson EW, Gelatinase A (MMP-2) activation by skin fibroblasts, dependence on MT1-MMP expression and fibrillar collagen form. Matrix Biol 2001;20:193-203.
26. Mirastschijski U, Impola U, Karsdal MA, Saarialho-Kere U, Ågren MS. Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. J Invest Dermatol 2002;118:55-64.
27. Brown NJ, Smyth EA, Cross SS, Reed MW. Angiogenesis induction and regression in human surgical wounds. Wound Rep Reg 2002;10:245-51.
28. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 1998;58:3743-50.
29. Nakamura Y, Hammarström L, Lundberg E, Ekdahl H, Matsumoto K, Gestrelius S, Lyngstadaas SP. Enamel matrix derivative promotes reparative processes in the dental pulp. Adv Dent Res 2001;15:105-7.
30. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
31. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
32. Yao F, Visovatti S, Johnson CS, Chen M, Slama J, Wenger A, Eriksson E. Age and growth factors in porcine full-thickness wound healing. Wound Rep Reg 2001;9:371-7.
33. Mirastschijski U, Impola U, Karlsmark T, Ågren MS, Saarialho-Kere U. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds. Hum Pathol 2002;33:355-64.
34. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998;58:1048-51.
35. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S, Azar DT. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 2001;508:187-90.
36. Lamoreaux WJ, Fitzgerald MEC, Reiner A, Hasty KA, Charles ST. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998;55:29-42.
37. Caron C, Xue J, Sun X, Simmer JP, Bartlett JD. Gelatinase A (MMP-2) in developing tooth tissues and amelogenin hydrolysis. J Dent Res 2001;80:1660-4.
38. Woessner JF Jr. Role of matrix proteases in processing enamel proteins. Connect Tissue Res 1998;39:69-73.
39. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res 2001;36:367-76.
40. Ågren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999;112:463-9.
41. Loots MAM, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93-9.
42. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC. Cellular dysfunction in the diabetic fibroblast, impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 2003;162:303-12.
43. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003;46:546-55.
44. Lauer G, Sollberg S, Cole M, Flamme I, Sturzebecher J, Mann K, Krieg T, Eming SA. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2000;115:12-8.
45. Drinkwater SL, Smith A, Sawyer BM, Burnand KG. Effect of venous ulcer exudates on angiogenesis in vitro. Br J Surg 2002;89:709-13.